Knowledge is power. Are you facing a new diagnosis or recurrence of Ankylosing Spondylitis (AS)? The Spine Community Ankylosing Spondylitis (AS) Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Ankylosing Spondylitis (AS). Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. Learn more about Ankylosing Spondylitis (AS).
You are not alone—The Spine Community is the leading Social Media Application for individuals seeking information, inspiration, and support for back pain and conditions of the spine. The network offers patients and caregivers a thriving community for support and information. Login or register here.
October 26th, 2017
The US Food and Drug Administration recently approved Simponi (golimumab) for the treatment of adult patients with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS), which is administered as a 30-minute infusion. Simponi was originally approved in 2013 for the treatment of moderate-to-severe active rheumatoid arthritis. Simponi® is one of five marketed TNF inhibitors […]
October 16th, 2017
The SpineCommunity Presents: Ask the Expert with Dr. David Borenstein David G. Borenstein, MD recently answered your questions on ankylosing spondylitis (AS) in TheSpineCommunity. TheSpineCommunity is an online support community for individuals affected with conditions of the spine, join the conversation here. Question: Has anyone compared the TNF inhibitors to the IL17 inhibitors? Is […]
October 12th, 2017
The SpineCommunity Presents: Ask the Expert with Dr. David Borenstein Ask the Expert: Focus on Ankylosing Spondylitis David G. Borenstein, MD recently answered your questions on ankylosing spondylitis (AS) in TheSpineCommunity. TheSpineCommunity is an online support community for individuals affected with conditions of the spine. Check out the Q&A with Dr. Borenstein by clicking on […]
July 20th, 2017
There is an increased mortality of ankylosing spondylitis (AS) patients compared to the general population. Factors that contributed to this increased mortality are a lower level of education, and the development of diabetes, infections, and pulmonary and cardiovascular diseases. Overall, doctors estimate there is a 53% increased risk of mortality for men, and a 83% […]
November 16th, 2016
By David Borenstein MD, Executive Editor, theSpineCommunity.com Prescription opioid or narcotic use is associated with an increasing number of deaths with approximately 20,000 victims in 2014 according to the National Center for Health Statistics from the Centers for Disease Control and Prevention (CDC). These unfortunate deaths have brought into question the benefit of opioid analgesics in […]
January 18th, 2016
Interleukin-17 (IL-17) is a protein produced by immune cells that you may not think of at any time during your busy day. But, if you are an individual with ankylosing spondylitis (AS), you should be interested. It seems that this cytokine (a messenger between cells) plays an important role in the symptoms associated with AS, […]
January 12th, 2016
An article from Swedish researchers reports on another difficulty that women with ankylosing spondylitis (AS) experience – pregnancy problems. A greater frequency of cesarean or C-section deliveries and offspring more often preterm and small for gestational age (SGA) occur more commonly in AS mothers. This Swedish Registry study examined 388 deliveries from women with AS […]